#ESCCongress: Findings from DAPA-CKD Trial
- Cardio
- 30/08/2020
The main results of the DAPA-CK trial were presented today at ESC Congress 2020. Findings showed that dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failu
READ MORE